Ipath Series B Etf Last Dividend Paid
| VXX Etf | USD 43.88 1.88 4.11% |
iPath Series B fundamentals help investors to digest information that contributes to IPath Series' financial success or failures. It also enables traders to predict the movement of IPath Etf. The fundamental analysis module provides a way to measure IPath Series' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to IPath Series etf.
IPath |
iPath Series B ETF Last Dividend Paid Analysis
IPath Series' Last Dividend Paid refers to dividend per share(DPS) paid to the shareholder the last time dividends were issued by a company. In its conventional sense, dividends refer to the distribution of some of a company's net earnings or capital gains decided by the board of directors.
More About Last Dividend Paid | All Equity Analysis
Last Dividend | = | Last Profit Distribution AmountTotal Shares |
Many stable companies today pay out dividends to their shareholders in the form of the income distribution, but high-growth firms rarely offer dividends because all of their earnings are reinvested back to the business.
| Competition |
Based on the recorded statements, iPath Series B has a Last Dividend Paid of 0.0. This indicator is about the same for the Milleis Investissements Funds average (which is currently at 0.0) family and about the same as Trading--Miscellaneous (which currently averages 0.0) category. This indicator is about the same for all United States etfs average (which is currently at 0.0).
IPath Last Dividend Paid Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses IPath Series' direct or indirect competition against its Last Dividend Paid to detect undervalued stocks with similar characteristics or determine the etfs which would be a good addition to a portfolio. Peer analysis of IPath Series could also be used in its relative valuation, which is a method of valuing IPath Series by comparing valuation metrics of similar companies.IPath Series is currently under evaluation in last dividend paid as compared to similar ETFs.
IPath Fundamentals
| Return On Equity | 0.0479 | |||
| Return On Asset | 0.0035 | |||
| Profit Margin | 0 % | |||
| Revenue | 31.81 B | |||
| Net Income | 911 M | |||
| Cash And Equivalents | 107.3 B | |||
| Debt To Equity | 1.42 % | |||
| Cash Flow From Operations | 15.44 B | |||
| Number Of Employees | 127 | |||
| Beta | 9.16 | |||
| Total Asset | 821.82 M | |||
| One Year Return | (37.10) % | |||
| Three Year Return | (48.80) % | |||
| Five Year Return | (47.10) % | |||
| Net Asset | 821.82 M |
About IPath Series Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze iPath Series B's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of IPath Series using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of iPath Series B based on its fundamental data. In general, a quantitative approach, as applied to this etf, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether iPath Series B offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of IPath Series' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ipath Series B Etf. Outlined below are crucial reports that will aid in making a well-informed decision on Ipath Series B Etf:Check out IPath Series Piotroski F Score and IPath Series Altman Z Score analysis. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
The market value of iPath Series B is measured differently than its book value, which is the value of IPath that is recorded on the company's balance sheet. Investors also form their own opinion of IPath Series' value that differs from its market value or its book value, called intrinsic value, which is IPath Series' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because IPath Series' market value can be influenced by many factors that don't directly affect IPath Series' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between IPath Series' value and its price as these two are different measures arrived at by different means. Investors typically determine if IPath Series is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, IPath Series' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.